GeneDx is trading 5.75% down now at $64.50, with broader market pressure possibly contributing to the decline. - No clear company-specific announcement explaining the October 22 decline surfaced in available coverage. - Reports of tanker incidents near the Strait of Hormuz sent oil higher, while investors also weighed concerns about technology spending and growth. - U.S. markets and technology shares were under pressure.